Vir Biotechnology, Inc. (VIR)
7.56
-0.26
(-3.32%)
USD |
NASDAQ |
Feb 20, 16:00
7.565
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology EPS Diluted (Quarterly) : -1.174 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.098 |
| Merck & Co., Inc. | 1.191 |
| Eton Pharmaceuticals, Inc. | -0.0716 |
| Sensei Biotherapeutics, Inc. | -3.915 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -163.14M |
| Revenue (Quarterly) | 0.24M |
| Total Expenses (Quarterly) | 163.38M |
| Enterprise Value | 643.23M |
| Gross Profit Margin (Quarterly) | -1.14K% |
| Profit Margin (Quarterly) | -67.98K% |
| Earnings Yield | -47.88% |
| Normalized Earnings Yield | -46.15 |